Скачать или смотреть Weight Loss Drug Wegovy in India: Miracle Cure or Health Risk? | Experts Explains | India

Novo Nordisk’s once-a-week weight-loss drug Wegovy has officially entered the Indian market — but is this the miracle solution to obesity or a shortcut with serious health risks?

In this exclusive segment, renowned Indian cardiologist Dr. Mohsin Wali breaks down the facts behind semaglutide, the active ingredient in Wegovy, and why it’s NOT a quick fix. He shares critical insights about who should (and shouldn’t) be taking it, and how it impacts the heart, metabolism, and long-term wellness.

With India’s obesity and diabetes rates on the rise, are we treating the symptoms or addressing the root cause?

Know your risks before they strike you — Dr. Wali warns against self-medication and blind trust in viral health trends. Don’t miss this must-watch health alert.